GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Vivus, Inc. (VVUS) [hlAlert]

Rating:
Buy VVUS
down 27.92 %

Vivus, Inc. (VVUS) upgraded to Buy with price target $2.80 by WallachBeth

Posted on: Thursday,  Nov 5, 2015  8:25 AM ET by WallachBeth

WallachBeth rated Buy Vivus, Inc. (NASDAQ: VVUS) on 11/05/2015, when the stock price was $1.54. Since
then, Vivus, Inc. has lost 27.92% as of 01/25/2016's recent price of $1.11.
If you would have followed this WallachBeth's recommendation on VVUS, you would have lost 27.92% of your investment in 81 days.

Vivus, Inc. is a leader in the development and commercialization of innovative therapies for the treatment of sexual dysfunction and urologic disorders in men and women. They develop and market the product MUSE and the medical device ACTIS, two innovations in the treatment of erectile dysfunction. The company has partnered with Abbott Laboratories for the international marketing and distribution of its male erectile dysfunction products. VIVUS also has research and development programs in premature ejaculation and erectile dysfunction. (Company Press Release)

WallachBeth
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/5/2015 8:25 AM Buy
None
1.54 2.80
as of 10/17/2014
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/25/2014 2:25 PM Hold
None
5.89 8.00
11/15/2013 8:25 AM Hold
None
9.20 11.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy